MedPath

Ebselen

Generic Name
Ebselen
Drug Type
Small Molecule
Chemical Formula
C13H9NOSe
CAS Number
60940-34-3
Unique Ingredient Identifier
40X2P7DPGH

Overview

Ebselen has been investigated for the treatment and basic science of Meniere's Disease, Type 2 Diabetes Mellitus, and Type 1 Diabetes Mellitus.

Background

Ebselen has been investigated for the treatment and basic science of Meniere's Disease, Type 2 Diabetes Mellitus, and Type 1 Diabetes Mellitus.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 3
Not yet recruiting
Posted: 2025/03/05
Sponsor:
Sound Pharmaceutical...
Phase 2
Not yet recruiting
Posted: 2024/04/01
Sponsor:
Sound Pharmaceutical...
Phase 3
Completed
Posted: 2020/12/21
Sponsor:
Sound Pharmaceutical...
Phase 2
Posted: 2020/07/23
Sponsor:
Sound Pharmaceutical...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath